Skip to main content
. 2020 Mar 30;9(4):957. doi: 10.3390/jcm9040957

Table 2.

Effect of HESr on IPSS as add-on therapy in men under a1-blockers.

Group n Range Mean (SD) p
HESr + a1-blocker IPSS1 24 8–20 13.3 (3.9) 0.006
IPSS2 24 8–22 11.3 (3.3)
A1-blocker IPSS1 23 8–20 13.5 (3.8) 0.346
IPSS2 23 8–22 13.3 (3.5)

HESr: hexanic lipidosterolic extract of Serenoa repens, IPSS: International Prostatic Symptoms Score, IPSS 1: IPSS at baseline, IPSS2: IPSS at 6 months, N: number of patients, SD: standard deviation.